-
Mashup Score: 0Osteoporosis in PsA: Dr. Rachel Tate - 3 year(s) ago
Dr. Rachel Tate discusses Abstract #1325, presented at the ACR 2021 annual meeting.
Source: YouTubeCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2Create new account | RheumNow - 3 year(s) ago
Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for Rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.
Source: rheumnow.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow https://t.co/riyAnrRHhX https://t.co/IEjvmn7glF
-
-
Mashup Score: 1Create new account | RheumNow - 3 year(s) ago
Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for Rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.
Source: rheumnow.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow https://t.co/riyAnrRHhX https://t.co/XzgOL16X0D
-
-
Mashup Score: 4Create new account | RheumNow - 3 year(s) ago
Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for Rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.
Source: rheumnow.comCategories: Latest Headlines, RheumatologyTweet-
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow https://t.co/riyAnrRHhX https://t.co/pEmkY9iX7G
-
-
Mashup Score: 0Create new account | RheumNow - 3 year(s) ago
Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for Rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.
Source: rheumnow.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
We’ve got you covered during ACR! Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow https://t.co/riyAnrRHhX https://t.co/AdVPCYVrag
-
-
Mashup Score: 0Create new account | RheumNow - 3 year(s) ago
Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for Rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.
Source: rheumnow.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow https://t.co/riyAnrRHhX https://t.co/XIJIMdvQ2g
-
-
Mashup Score: 5Create new account | RheumNow - 3 year(s) ago
Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for Rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.
Source: rheumnow.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
We’ve got you covered during ACR! Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow https://t.co/riyAnrRHhX https://t.co/GYhAiZkygd
-
-
Mashup Score: 2Pfizer/Lilly Pull Tanezumab Development | RheumNow - 3 year(s) ago
Today, Lilly and Pfizer announced their global clinical development of the NGF inhibitor, tanezumab, has been discontinued due to recent negative opinions from the EMA and FDA advisory committee. This decision mirrors that of other companies (AbbVie, AstraZeneca, Johnson & Johnson) who, in the last 10 years, have halted NGF inhibitor development due to FDA concerns over risk/benefit in patients…
Source: rheumnow.comCategories: Latest Headlines, RheumatologyTweet-
Lilly and Pfizer announced their global clinical development of the NGF inhibitor, tanezumab, has been discontinued due to recent negative opinions from the EMA and FDA advisory committee. Read more on #RheumNow https://t.co/6YrguECLi6 https://t.co/V1E3Yj4aUa
-
-
Mashup Score: 0Create new account | RheumNow - 3 year(s) ago
Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for Rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.
Source: rheumnow.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow https://t.co/riyAnrRHhX https://t.co/MkoDsw34D0
-
-
Mashup Score: 1
Pregnancy outcomes may be affected by psoriatic arthritis or antirheumatic treatment; registry cohort study shows that preterm birth and cesarean delivery were mostly increased by antirheumatic treatment, especially biologics. A nationwide Swedish register studied 921 PsA-pregnancies and compared outcomes to a matched (1:10) cohort of and 9210 non-PSA-pregnancies. Adjusted odds ratios (aOR) were…
Source: rheumnow.comCategories: Latest Headlines, RheumatologyTweet-
Pregnancy outcomes may be affected by psoriatic arthritis or antirheumatic treatment; registry cohort study shows that preterm birth and cesarean delivery were mostly increased by antirheumatic treatment, especially biologics. Read more on #RheumNow https://t.co/UVpUpUt5jE https://t.co/Urr69V04ee
-
RT @uptoTate: Check out my #RheumNow highlights from #ACR21 discussing OP in PsA https://t.co/dpfT7FjyjA